First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value

Overview of attention for article published in Lung, July 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy: 1 policy source

twitter: 3 X users

Citations

dimensions_citation: 105 Dimensions

Readers on

mendeley: 84 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,955 followers.

I'm reading this on #springerlink https://t.co/5HpAKxhCoA

Reply Repost Favourite

Efficacy and Safety of Nintedanib in Patients with IPF & FVC pred of ≤50% https://t.co/N97Ns8SIcJ

Reply Repost Favourite

#Nintedanib in pts. w/ Idiop. #PulmonaryFibrosis and FVC<50% has comparable effects as in those with FVC>50% https://t.co/BFplmStBnl

Reply Repost Favourite